Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California.
In GK, Vaidya P, Filkins A, Hermel DJ, King KG, Ragab O, Tseng WW, Swanson M, Kokot N, Lang JE, Menendez L, DeClerck B, Kim G, Hu JC, Terando A, Jadvar H, Ricker C, Miller KA, Peng DH, Wysong A. In GK, et al. Among authors: terando a. J Cancer Res Clin Oncol. 2021 Jun;147(6):1803-1811. doi: 10.1007/s00432-020-03458-6. Epub 2020 Nov 18. J Cancer Res Clin Oncol. 2021. PMID: 33210210
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.
In GK, Nallagangula A, Choi JS, Tachiki L, Blackburn MJ, Capone S, Bollin KB, Reuben DY, Shirai K, Zhang-Nunes S, Ragab O, Terando A, Hu JC, Lee H, Bhatia S, Chandra S, Lutzky J, Gibney GT. In GK, et al. Among authors: terando a. J Immunother Cancer. 2022 May;10(5):e004839. doi: 10.1136/jitc-2022-004839. J Immunother Cancer. 2022. PMID: 35545318 Free PMC article.
Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.
Culver JO, Freiberg Y, Ricker C, Comeaux JG, Chang EY, Banerjee V, Sturgeon D, Solomon I, Kagey J, Dobre MG, Carey J, Carr A, Cho S, Lu J, Kang IM, Patel K, Terando A, Ye JC, Li M, Lerman C, Spicer D, Nelson M. Culver JO, et al. Among authors: terando a. Ann Surg Oncol. 2023 Feb;30(2):1017-1025. doi: 10.1245/s10434-022-12595-w. Epub 2022 Sep 26. Ann Surg Oncol. 2023. PMID: 36161375 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36319870
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis.
Vreeland TJ, Clifton GT, Hale DF, Chick RC, Hickerson AT, Cindass JL, Adams AM, Bohan PMK, Andtbacka RHI, Berger AC, Jakub JW, Sussman JJ, Terando AM, Wagner T, Peoples GE, Faries MB. Vreeland TJ, et al. Ann Surg Oncol. 2021 Oct;28(11):6126-6137. doi: 10.1245/s10434-021-09709-1. Epub 2021 Feb 27. Ann Surg Oncol. 2021. PMID: 33641012 Free PMC article. Clinical Trial.
Melanoma: adjuvant therapy and other treatment options.
Terando A, Sabel MS, Sondak VK. Terando A, et al. Curr Treat Options Oncol. 2003 Jun;4(3):187-99. doi: 10.1007/s11864-003-0020-0. Curr Treat Options Oncol. 2003. PMID: 12718796 Review.
59 results